Core Insights - Despite the active performance of sectors like technology, new consumption, and pharmaceuticals, investors have found it challenging to achieve ideal returns, with the CSI 300 index showing a mere 0.03% increase year-to-date as of June, contrasting sharply with the nearly 8% rise in the Wind Active Equity Mixed Fund Index, highlighting the scarcity of professional research capabilities in volatile markets [1] Group 1: Fund Performance - In Q2, public funds achieved a total profit of 386.3 billion yuan, with Fuqun Fund ranking fifth in the industry with a profit of 19.492 billion yuan. For the first half of the year, Fuqun Fund generated 29.832 billion yuan for investors, placing it fourth overall [2] - Fuqun Fund's active equity research strength is a core competitive advantage, with 11 of its equity funds ranking in the top 10 of their categories over the past year. Notably, Fuqun Medical Innovation Stock A and Fuqun Active Growth One-Year Regular Open Mixed Fund both exceeded 40% in returns [2][3] Group 2: Long-term Performance - Over the past five and seven years, Fuqun Fund has had 5 and 10 products, respectively, ranking in the top 10 of their categories. Fuqun New Vitality Flexible Allocation Mixed A achieved returns of 67.84% and 175.32% over the past five and seven years, respectively, ranking first in its category [4] - Fuqun Global Consumer Selection A, managed by a Hong Kong fund manager, has shown impressive long-term performance with returns of 86.16% and 70.68% over the past two and three years [3] Group 3: Fixed Income and Quantitative Strategies - In the fixed income sector, Fuqun Fund's products have maintained a "steady" approach despite market challenges. Fuqun Strong Return Regular Open Bond A achieved returns of 13.03%, 23.28%, and 45.09% over three, five, and seven years, respectively, ranking in the top 9% of its category [5] - Fuqun Fund's quantitative strategies have also performed well, with 10 of its quantitative funds ranking in the top 10 of their categories over the past year. The classic broad-based ETF, the Shanghai Composite Index ETF, has consistently ranked in the top 5 over three, five, and seven years [6]

Group 1 - The core viewpoint of the report indicates that the construction materials and coal industries performed well during the period, with the Shanghai Composite Index rising by 1.67% and the Shenzhen Component Index increasing by 2.33% [2][9] - In the recent 12 periods, the comprehensive and pharmaceutical industries showed strong performance, suggesting potential investment opportunities in these sectors [9] - Active equity funds focusing on electronics and coal industries also demonstrated superior performance during this period [14] Group 2 - Among various fund types, actively managed stock funds increased by 1.55%, while mixed funds rose by 1.63%, and bond funds saw a slight decline of 0.16% [2] - The average return of convertible bond funds was notably high at 12.46% year-to-date, indicating a strong performance in this category [17] - QDII funds, particularly those focused on Asia-Pacific and emerging markets, led the performance with an increase of 2.56% during the period [19][21]

Core Viewpoint - The article emphasizes the continuous improvement and advancement of the investment research system at Fuqun Fund, highlighting its strong performance in equity investment and the growing demand for stable mid-to-long-term investment products in the Chinese market [1][4][6]. Group 1: Market Context - As Chinese residents' wealth continues to grow, the demand for asset allocation is increasing, making public funds an important part of investment choices [3]. - Investors are increasingly focused on long-term performance rather than just short-term results, leading to a more rigorous evaluation of fund performance [3]. Group 2: Fuqun Fund's Performance - Fuqun Fund's active equity funds have demonstrated excellent investment capabilities, with a 20-year return of 953.86%, ranking 4th in the industry [6]. - As of June 30, 2025, 11 of Fuqun Fund's equity funds ranked in the top 10 of their categories for the past year, with several funds achieving returns exceeding 40% [8]. Group 3: Specific Fund Highlights - Fuqun Medical Innovation Stock A achieved a return of 58.87% over the past year, ranking 2nd among 45 funds in the medical and healthcare sector [8]. - Fuqun Consumption Select 30 Stock A has performed well in the new consumption investment trend, ranking 2nd among 38 funds in the consumption sector over the past year [8]. Group 4: Fixed Income and Hybrid Products - Fuqun Fund's fixed income products have shown strong performance, with Fuqun Strong Return Bond A achieving returns of 13.03%, 23.28%, and 45.09% over the past three, five, and seven years, respectively, ranking in the top 9 of its category [10]. - The "fixed income + equity" products, such as Fuqun Enhanced Bond and Fuqun Jiuli Stable Allocation Mixed A, have also performed well, with returns of 28.74% and 41.24% over the past year, ranking first in their categories [11]. Group 5: Quantitative Investment - Fuqun Fund's quantitative products have consistently ranked well, with 10 quantitative funds placing in the top 10 of their categories over the past year [12]. - The classic ETF, Fuqun Shanghai Composite Index ETF, has also performed well, ranking among the top five in its category over the past three, five, and seven years [12].